Perhexiline
Brand names,
Perhexiline
Analogs
Perhexiline
Brand Names Mixture
Perhexiline
Chemical_Formula
C19H35N
Perhexiline
RX_link
No information avaliable
Perhexiline
fda sheet
Perhexiline
msds (material safety sheet)
Perhexiline
Synthesis Reference
No information avaliable
Perhexiline
Molecular Weight
277.488 g/mol
Perhexiline
Melting Point
No information avaliable
Perhexiline
H2O Solubility
0.0608 mg/L
Perhexiline
State
Solid
Perhexiline
LogP
6.054
Perhexiline
Dosage Forms
Tablet for oral administration (100 mg)
Perhexiline
Indication
For the management of severe angina pectoris.
Perhexiline
Pharmacology
Used in the treatment of unresponsive or refractory angina. Perhexiline increases glucose metabolism at the expense of free-fatty-acid metabolism, enhancing oxygen efficiency during myocardial ischaemia. Perhexiline also potentiates platelet responsiveness to nitric oxide both in patients with angina and patients with acute coronary syndrome. The predominant mechanism of this particular perhexiline effect is an increase in platelet cGMP responsiveness. Perhexiline also may reduce the potential for nitric oxide clearance by neutrophil-derived oxygen. Perhexiline relieves symptoms of angina, improves exercise tolerance, and increases the workload needed to induce ischaemia when used as monotherapy. The primary therapeutic roles for perhexiline are as short-term therapy (less than 3 months duration) in patients with severe ischaemia awaiting coronary revascularisation or long-term therapy in patients with ischaemic symptoms refractory to other therapeutic measures.
Perhexiline
Absorption
Well absorbed (>80%) from the gastrointestinal tract following oral administration.
Perhexiline
side effects and Toxicity
Oral LD50 Rat: 2150 mg/kg; Oral LD50 Mouse: 2641 mg/kg. Short term adverse effects include nausea, transient dizziness, hypoglycaemia in diabetic patients, and torsade de pointes (rare).
Perhexiline
Patient Information
No information avaliable
Perhexiline
Organisms Affected
Humans and other mammals